Viewing StudyNCT05748171



Ignite Creation Date: 2024-05-06 @ 6:40 PM
Last Modification Date: 2024-10-26 @ 2:52 PM
Study NCT ID: NCT05748171
Status: RECRUITING
Last Update Posted: 2024-06-18
First Post: 2023-01-20

Brief Title: A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin InO in Children 1 to 18 Years With First Relapse ALL
Sponsor: Pfizer
Organization: Pfizer

Conditions & Keywords Data

Conditions:
Name
ACUTE LYMPHOBLASTIC LEUKEMIA
Keywords:
Name View
Leukemia View
ALL View
BCP ALL View
High risk BCP ALL View
Relapse ALL View